切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Topoisomerases - Kallikrein - Na /H Exchangers (NHEs) - Cytochrome P450 (CYP450)

32件产品中的 1-10

页面
每页
清除全部
  1. 7-Ethoxyresorufin
    B5963 7-Ethoxyresorufin
    中文名: 乙氧基试卤灵,7-乙氧基-3H-吩恶嗪-3-酮
    Target: Cytochrome P450 (CYP450)
    Summary: CYP1A特异性底物
      Soluble in DMSO
  2. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  3. EIPA
    B7389 EIPA
     3 Citation
    Target: Na /H Exchangers (NHEs)
    Summary: TRPP3通道抑制剂
      Soluble in DMSO
  4. Quinidine
    B7590 Quinidine
    中文名: 奎尼丁
    Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)
    Summary: 降低Na+和K+通道电流
      ≥11.95 mg/mL
      insoluble in H2O
  5. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  6. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  7. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  8. Fluconazole
    B2094 Fluconazole
    中文名: 氟康唑
    Target: Cytochrome P450 (CYP450)
    Summary: 三唑抗真菌剂
      ≥10.9 mg/mL
      insoluble in H2O
  9. Rifabutin
    B2126 Rifabutin
    中文名: 利福布丁
    Target: Cytochrome P450 (CYP450)
    Summary: 抗结核药物
      ≥42.35 mg/mL
      insoluble in H2O
  10. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL

32件产品中的 1-10

页面
每页